Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pomegranate Juice Consumption by Patients Under Medication for Addiction Treatment as a Regulator of Craving and Blood Redox Status: The Study Protocol of a Randomized Control Trial (the NUTRIDOPE Study)

NCT05861544 is registered in ClinicalTrials.gov with Organization Against Drugs (ΟΚΑΝΑ) as lead sponsor.

NCT NCT05861544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05861544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pomegranate Juice Consumption by Patients Under Medication for Addiction Treatment as a Regulator of Craving and Blood Redox Status: The Study Protocol of a Randomized Control Trial (the NUTRIDOPE Study)
Lead sponsor
Organization Against Drugs (ΟΚΑΝΑ)
Phase
Not applicable
Overall status
Unknown status
Start date
March 23, 2023
Completion date
January 23, 2024
Enrollment
58 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psychiatry